Ideal pharmacotherapy for allergic rhinitis.
نویسنده
چکیده
The characteristics of the "ideal" pharmacotherapeutic agent for managing the symptoms of seasonal allergic rhinitis and the advantages and disadvantages of the pharmacotherapeutic agents that are currently available are reviewed. Decongestants, mast cell stabilizers, anticholinergics, intranasal steroids, and oral antihistamines and their place in the therapeutic armamentarium of the clinician are discussed.
منابع مشابه
The cost-effectiveness of immunotherapy for respiratory allergy: a review.
This article reviews the international literature on the cost-effectiveness of immunotherapy for respiratory allergy. Included studies conducted an economic evaluation of immunotherapy for allergic rhinoconjunctivitis, allergic conjunctivitis, allergic rhinitis, asthma or allergic rhinitis in combination with asthma. Although there were few economic evaluations and these suffered from methodolo...
متن کاملThe pharmacotherapy preferred by doctors in treatment of patients diagnosed with asthma or chronic obstructive pulmonary disease or allergic rhinitis and concomitant diseases: an epidemiological analysis
INTRODUCTION The clinical course of asthma and chronic obstructive pulmonary disease (COPD) is influenced by the co-occurrence of other chronic diseases and their pharmacotherapy. There are no data associated with the doctors' pharmacotherapy preferences in treatment of patients with asthma, COPD or allergic rhinitis and concomitant diseases. AIM The assessment of doctors' preferences in phar...
متن کاملFluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis
Of the classes of pharmacotherapy for seasonal allergic rhinitis, intranasal corticosteroids are the preferred treatment and are recommended in practice guidelines as first-line pharmacotherapy for rhinitis with prominent nasal congestion. The enhanced-affinity intranasal corticosteroid fluticasone furoate nasal spray (GW685698X), is one of the newest additions to the armamentarium for allergic...
متن کاملTreatment of congestion in upper respiratory diseases
Congestion, as a symptom of upper respiratory tract diseases including seasonal and perennial allergic rhinitis, acute and chronic rhinosinusitis, and nasal polyposis, is principally caused by mucosal inflammation. Though effective pharmacotherapy options exist, no agent is universally efficacious; therapeutic decisions must account for individual patient preferences. Oral H(1)-antihistamines, ...
متن کاملImmunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy.
BACKGROUND Chronic pharmacotherapy is recommended to patients with persistent moderate-severe (PM-S) allergic rhinitis (AR). The cost of pharmacotherapy is the main barrier to achieve symptoms control. AIMS OF THE STUDY To determine the benefits of mite subcutaneous immunotherapy (SIT) in patients with PM-S AR not satisfied with chronic pharmacotherapy received free of charge. METHODS Open ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of allergy and clinical immunology
دوره 103 3 Pt 2 شماره
صفحات -
تاریخ انتشار 1999